Apollo Hospitals Enterprise: Morgan Stanley on Apollo Hospitals Enterprise maintains Overweight with Target Price ₹8,833 (cut from ₹9,209) citing EBITDA cuts from ramp-up losses in new hospitals, higher Apollo 24/7 operating costs, ~2.5–3% EPS downgrade for FY27-28, while revenue outlook remains intact despite persistent margin pressures.

 08 Apr 2026 08:57 AM

Apollo Hospitals Enterprise: Morgan Stanley on Apollo Hospitals Enterprise maintains Overweight with Target Price ₹8,833 (cut from ₹9,209) citing EBITDA cuts from ramp-up losses in new hospitals, higher Apollo 24/7 operating costs, ~2.5–3% EPS downgrade for FY27-28, while revenue outlook remains intact despite persistent margin pressures.